WHO ICTRP trial
Exploratory placebo-controlled double-blind study of NS-580 in patients with…
JPRN-jRCT2031230134 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-jRCT2031230134 |
|---|---|
| Public title | Exploratory placebo-controlled double-blind study of NS-580 in patients with chronic prostatitis/chronic pelvic pain syndrome (early phase II) |
| Scientific title | Exploratory placebo-controlled double-blind study of NS-580 in patients with chronic prostatitis/chronic pelvic pain syndrome (early phase II) |
| Primary sponsor | Higashioka Masaya |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Conditions | Chronic prostatitis/Chronic pelvic pain syndrome(CP/CPPS) |
| Interventions | Participant will receive one of two oral doses of NS-580 and/or placebo over a treatment period. |
| Registration date | Jun 13, 2023 |
| Target size | 150 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: